No, Liam. It's and just to be clear, this isn't new market share loss. Right? What we announced in November was planned for in 2025. Some of that started happening in terms of plant conversions in the fourth quarter, which was before we had expected, but it's the same share loss that we had mentioned back in November. Yeah, it's look, we have grown market share significantly, you know, in the time that we've owned that business. You know, to the point where, you know, most of the top treaters were sole-sourced with us. And I think, you know, over time, you know, they look to diversify their supply chain and mitigate some risk. They're, you know, they were looking to, you know, split a little bit of that business, and, you know, you had a competitor that had changed hands in terms of ownership. Some investments were made to be more aggressive in going after business, and, you know, it's purely what it is. I think it's a diverse risk on some of our customers' ends and an aggressive competitor who put some money into capacity to try and improve their overall business. Yeah. It's one of those things that as you continue to grow and get bigger and increase market share, you get to a point where, obviously, there's a greater risk and likelihood that you're going to go backwards rather than forwards. And so that's kind of where we found ourselves, and we're a little bit of a victim of our own success over the past ten years.